Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05495334 · ClinicalTrials.gov registry record

Innovations in Genicular Outcomes Registry

A clinical trial of Knee Osteoarthritis, sponsored by Pacira Pharmaceuticals.

Recruiting
Registry status
10,000
Enrollment target
17
Study locations

NCT05495334: Recruiting study of Knee Osteoarthritis, sponsored by Pacira Pharmaceuticals.

NCT05495334 is a study of Knee Osteoarthritis that is actively recruiting participants, run by Pacira Pharmaceuticals. The registered enrollment target is 10,000 participants, above the 205-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (4778% higher). The trial reports 17 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05495334, a study of Knee Osteoarthritis, is actively recruiting participants, sponsored by Pacira Pharmaceuticals.

RECRUITING
Registry status
10,000 participants
Enrollment target
17
Study locations

Study Summary

The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs \[NSAIDs\]).

Primary Outcome

NRS score from 0(being none)-10(being the worst)

Conditions Studied

Interventions

  • PROCEDURE Treatment for Knee OA

Study Locations (17)

California

  • Orthopedic Education and Research Institute of So Ca (Hoag) - Irvine
  • Cedars-Sinai Medical Center - Los Angeles

Louisiana

  • MidState Orthopedics and Sports Medicine - Alexandria
  • Louisiana State University /Ochsner - New Orleans

Maryland

  • Sinai Hospital of Baltimore - Baltimore
  • Henry M Jackson Foundation for the Advancement of Military Medicine/Walter Reed National Military Medical Center - Bethesda

New York

  • Northwell Health - Garden City
  • Genesee Orthopedics and Plastic Surgery (St. Elizabeth Med Center/ Apex Surgical Center) - New Hartford

Pennsylvania

  • Penn Highlands DuBois - DuBois
  • University Orthopedics Center - State College

Arizona

  • The MORE Foundation - Phoenix

Nebraska

  • OrthoNebraska Clinics - Omaha

New Jersey

  • Jersey City Medical Center - Jersey City

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2021-09-23
Est. Completion 2033-12-30
Pacira Pharmaceuticals

88 total trials

What NCT05495334 shows while recruiting

NCT05495334 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 205-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (4778% higher).

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Treatment for Knee OA is the first listed.

NCT05495334 lists 17 locations in 12 states (California, Louisiana, Maryland).

Frequently Asked Questions

What is clinical trial NCT05495334 about?

NCT05495334 is a clinical study titled "Innovations in Genicular Outcomes Registry". The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) cortico...

What is the current status of trial NCT05495334?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2021-09-23. Estimated completion is 2033-12-30.

What conditions does trial NCT05495334 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT05495334?

The interventions under investigation include: Treatment for Knee OA (PROCEDURE).

Who is sponsoring clinical trial NCT05495334?

This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05495334 being conducted?

This trial has 17 study locations across Arizona, California, Louisiana, Maryland, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05495334's enrollment target sits among peer trials

10,000 1st of 101 higher than 101 of 101 other Knee Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05495334, the US trial registry maintained by the National Library of Medicine. NCT05495334 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.